Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma

[1]  Chao Jing,et al.  Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion , 2018, International journal of oncology.

[2]  Y. Miki,et al.  LAMC2 is a predictive marker for the malignant progression of leukoplakia , 2017, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[3]  Zeming Liu,et al.  Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis , 2016, World Journal of Surgical Oncology.

[4]  G. Calaf,et al.  Ras protein expression as a marker for breast cancer , 2016, Oncology letters.

[5]  M. Gallottini,et al.  PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[6]  C. Van Waes,et al.  The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies. , 2015, Oral diseases.

[7]  Yih-Leong Chang,et al.  Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases. , 2015, Oral oncology.

[8]  Heng-Yu Chang,et al.  Expression of aquaporin 8 and phosphorylation of Erk1/2 in cervical epithelial carcinogenesis: correlation with clinicopathological parameters. , 2014, International journal of clinical and experimental pathology.

[9]  G. Gillet,et al.  Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism. , 2013, Cancer research.

[10]  M. Elsabah,et al.  Immunohistochemical assay for detection of K-ras protein expression in metastatic colorectal cancer. , 2013, Journal of the Egyptian National Cancer Institute.

[11]  Jun Yu,et al.  Expression of C-X-C chemokine receptor types 1/2 in patients with gastric carcinoma: Clinicopathological correlations and significance , 2012, Oncology letters.

[12]  Jin-Hyoung Kang,et al.  Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma. , 2012, Oral oncology.

[13]  Jiawei Wang,et al.  Stat3 is involved in the motility, metastasis and prognosis in lingual squamous cell carcinoma , 2012, Cell biochemistry and function.

[14]  J. Bussink,et al.  Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  F. Fonseca,et al.  TWIST and p-Akt immunoexpression in normal oral epithelium oral dysplasia and in oral squamous cell carcinoma , 2011, Medicina oral, patologia oral y cirugia bucal.

[16]  H. Weiss,et al.  mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. , 2011, Cancer research.

[17]  R. Ralhan,et al.  Prognostic significance of nuclear pSTAT3 in oral cancer , 2011, Head & neck.

[18]  S. Shukla,et al.  Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis , 2009, Head & neck.

[19]  H. Pontes,et al.  Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma: an immunohistochemical study. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[20]  S. Warnakulasuriya.  Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.

[21]  H. Kuwano,et al.  Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy , 2008, Molecular carcinogenesis.

[22]  E. Nkenke,et al.  Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis , 2007, Journal of Cancer Research and Clinical Oncology.

[23]  K. Stoltze,et al.  Long-term treatment outcome of oral premalignant lesions. , 2006, Oral oncology.

[24]  J. Woolgar,et al.  Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. , 2006, Oral oncology.

[25]  J. Kim,et al.  Prognostic value of activated Akt expression in oral squamous cell carcinoma , 2005, Journal of Clinical Pathology.

[26]  S. Dunner,et al.  H-ras immunohistochemical expression and molecular analysis of urinary bladder lesions in grazing adult cattle exposed to bracken fern. , 2005, Journal of comparative pathology.

[27]  Nhu D Le,et al.  Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[28]  J. Testa,et al.  Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. , 2004, Carcinogenesis.

[29]  Robert D Cardiff,et al.  Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. , 2004, Cancer research.

[30]  H. Lee,et al.  Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[31]  F. Sommerer,et al.  Mutations of the BRAF gene in squamous cell carcinoma of the head and neck , 2003, Oncogene.

[32]  J. Pouysségur,et al.  Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. , 2002, European journal of biochemistry.

[33]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[34]  T. Slaga,et al.  Functional roles of Akt signaling in mouse skin tumorigenesis , 2002, Oncogene.

[35]  J. Baselga,et al.  Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. , 2001, Cancer research.

[36]  C. Feng,et al.  A preliminary study on ras protein expression in human esophageal cancer and precancerous lesions. , 2000, World journal of gastroenterology.

[37]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[39]  E Yamamoto,et al.  Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. , 1984, Head & neck surgery.

[40]  J. Grandis,et al.  WHO classification of head and neck tumours , 2017 .

[41]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.